- 询价
- CellGenix
- 德国
- 1003-050
- 2025年07月15日
相关产品推荐更多 >
esxA/esxA蛋白Recombinant M_y_c_obacterium t_u_b_erculosis 6KDA early secretory antigenic target (esxA)重组蛋白ESAT-6蛋白
￥2616
重组蛋白IL-1 beta，Mouse，AF
￥600
MMP14/MMP14蛋白Recombinant Human Matrix metalloproteinase-14 (MMP14)重组蛋白MMP-X1Membrane-type matrix metalloproteinase 1 ;MT-MMP 1 ;MTMMP1Membrane-type-1 matrix metalloproteinase ;MT1-MMP ;MT1MMP蛋白
￥1344
N/A蛋白|萨尔莫沙拉N/A蛋白|萨尔莫沙拉N/A重组蛋白|Salmo salar N/A Recombinant Protein
￥2328重组蛋白IL-1 beta， Human，AF
￥600
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
6个月
- 英文名：
GMP Recombinant Human Interleukin-4 (rh IL-4), USP grade
- 库存：
1000
- 供应商：
重庆市华雅干细胞技术有限公司
- 保存条件：
-20°C
- 规格：
Pcs
品牌： CellGro®
厂家： CellGen
货号： 352096
货期：期货2-5周
欢迎来电咨询：023-63015781 18983631204（重庆） 15608500073（贵阳）QQ2233895903
GMP Recombinant Human Interleukin-4 (rh IL-4), USP grade USP级人重组白介素4产品信息：
Data Sheet: CellGro®/ CellGenix™
GMP Recombinant Human
Interleukin-4 (rh IL-4), USP grade
Order No.: 1003-050
Source
A DNA sequence encoding the mature IL-4 protein (Yakota, T. et al., 1986,
PNAS 83:5894) was expressed in E. coli
Molecular mass
The methionyl form of the E. coli expressed mature human IL-4 contains 130 amino acid residues and has a molecular mass of 14 kDa
Identity
Confirmed by DNA-sequencing of the expression plasmid in end of production (EOP)-cells, Western Blot, and N-terminal sequencing of the final product
Purity
≥97%, as determined by SDS-PAGE (under reducing and non-reducing
conditions) and visualized by Silver staining
Endotoxin level
< 50 EU/mg, as determined by LAL gel clot test according to Ph.Eur.
Residual host-cell DNA
≤1 ng/mg, as determined with the Threshold®system
Activity
0.5x107 – 2x107
USP units per mg1
Measured in a cell proliferation assay using a human factor-dependent cell line, TF-1 (Kitamura, T. et al., 1989, J. Cell Physiol. 140:323-334) USP units are equivalent to international units (IU)
Sterility
Sterility test according to Ph.Eur. of the vialed product (direct inoculation)
Formulation
Lyophilized from a 250 μg/ml, 0.2μm sterile-filtered solution in PBS without any carrier materials and preservatives
Amount per vial
50 ± 7.5 μg, as determined by spectrophotometrical measurement at 280 nm
using PBS as reference (A280= 0.63 for a concentration of 1 mg/ml IL-4 in PBS)
Transport
Ambient temperature
Storage at
-20°C or below. Avoid repeated freeze-thaw cycles
Shelf life
Minimum 6 months from date of shipping
Intended use
For clinical ex vivo use. Not intended for human in vivo application
Quality statement
This product is manufactured, tested and released in compliance with the relevant GMP-guidelines. No animal- or human-derived materials were used during manufacturing. This product complies with USP chapter “growth factors and cytokines used in cell therapy manufacturing”. USP chapter “ancillary materials for cell, gene, and tissue-engineered products” has been considered in the design of this product.
更多产品：
CellGro® GMP Cytokines
| DataSheet_GMP_Activin_A_ZY-DS-1022a.pdf | |
| DataSheet_GMP_EGF_ZY-DS-1016a.pdf | |
| DataSheet_GMP_FGF-2_ZY-DS-1021a.pdf | |
| DataSheet_GMP_Flt-3L_ZY-DS-1015a.pdf | |
| DataSheet_GMP_GM-CSF_ZY-DS-1012a.pdf | |
| DataSheet_GMP_IL-10_ZY-DS-1014a.pdf | |
| DataSheet_GMP_IL-15_ZY-DS-1013a.pdf | |
| DataSheet_GMP_IL-1beta_ZY-DS-1011b.pdf | |
| DataSheet_GMP_IL-21_ZY-DS-1019a.pdf | |
| DataSheet_GMP_IL-2_ZY-DS-1020a.pdf | |
| DataSheet_GMP_IL-3_ZY-DS-1002c.pdf | |
| DataSheet_GMP_IL-4_ZY-DS-1003b.pdf | |
| DataSheet_GMP_IL-6_ZY-DS-1004b.pdf | |
| DataSheet_GMP_IL-7_ZY-DS-1010a.pdf | |
| DataSheet_GMP_PDGF-BB_ZY-DS-1009b.pdf | |
| DataSheet_GMP_SCF_ZY-DS-1018a.pdf | |
| DataSheet_GMP_TNFalpha_ZY-DS-1006a.pdf | |
| DataSheet_GMP_TPO_ZY-DS-1017a.pdf |
CellGro® Preclinical Cytokines
| DataSheet_preclinical_Activin_A_ZY-DS-1422b.pdf | |
| DataSheet_preclinical_EGF_ZY-DS-1416a.pdf | |
| DataSheet_preclinical_FGF-2_ZY-DS-1421a.pdf | |
| DataSheet_preclinical_Flt-3L_ZY-DS-1415a.pdf | |
| DataSheet_preclinical_GM-CSF_ZY-DS-1412a.pdf | |
| DataSheet_preclinical_IL-10_ZY-DS-1414a.pdf | |
| DataSheet_preclinical_IL-15_ZY-DS-1415a.pdf | |
| DataSheet_preclinical_IL-1beta_ZY-DS-1411a.pdf | |
| DataSheet_preclinical_IL-21_ZY-DS-1419a.pdf | |
| DataSheet_preclinical_IL-2_ZY-DS-1420a.pdf | |
| DataSheet_preclinical_IL-3_ZY-DS-1402a.pdf | |
| DataSheet_preclinical_IL-4_ZY-DS-1403a.pdf | |
| DataSheet_preclinical_IL-6_ZY-DS-1404a.pdf | |
| DataSheet_preclinical_IL-7_ZY-DS-1410a.pdf | |
| DataSheet_preclinical_PDGF-BB_ZY-DS-1409a.pdf | |
| DataSheet_preclinical_SCF_ZY-DS-1418a.pdf | |
| DataSheet_preclinical_TNFalpha_ZY-DS-1406a.pdf | |
| DataSheet_preclinical_TPO_ZY-DS-1417a.pdf |
更多详情请来电:023-63015781 18983631204 15608500073 QQ:2233895903
重庆市华雅干细胞技术有限公司
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验for detection of viral nucleic acids using the FlowMetrixsystem[J]．CIin Chem，1998，44(9)：2054-2056．[7]Wong SJ，Demarest VL．Boyle RH．et al．Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay[J]．J Clin
。移植排斥（transplantation rejection ）是指受者免疫系统识别移植抗原后产生免疫应答，进而破坏移植物的过程。引起移植排斥的抗原为移植抗原（transplantation antigen），即组织相容性抗原，人类的主要组织相容性抗原称为人类白细胞抗原（human leukocyte antigen，HLA抗原），是主要组织相容性复合体(major histocompatibility complex, MHC)的编码产物，是移植排斥的分子基础。HLA-I类抗原（HLA-A、B
